253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham

D. Rea; A.D. Beggs; E. Efstathiou; J.D. Stockton; R.M. Worledge; C. Escribano Gonzalez; E. Turner; S. Pirrie; H. Cain; D. Cameron; D. Dodwell; L. Haywood; H. Earl; R. Stein; K. Herring; M. MacKenzie; A. Makris; C. Gaunt; E. Southgate; N. Morelli

doi:10.1016/j.ejca.2026.116516

253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham

D. Rea
, A.D. Beggs
, E. Efstathiou
, J.D. Stockton
, R.M. Worledge
, C. Escribano Gonzalez
, E. Turner
, S. Pirrie
, H. Cain
, D. Cameron
, D. Dodwell
, L. Haywood
, H. Earl
, R. Stein
, K. Herring
, M. MacKenzie
, A. Makris
, C. Gaunt
, E. Southgate
, N. Morelli

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Article number	116516
Pages (from-to)	118-119
Number of pages	2
Journal	European Journal of Cancer
Volume	237
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/j.ejca.2026.116516
Publication status	Published - 27 Mar 2026
Event	15th European Breast Cancer Conference - Barcelona, Spain Duration: 25 Mar 2026 → 27 Mar 2026

Access to Document

10.1016/j.ejca.2026.116516

Cite this

Rea, D., Beggs, A. D., Efstathiou, E., Stockton, J. D., Worledge, R. M., Escribano Gonzalez, C., Turner, E., Pirrie, S., Cain, H., Cameron, D., Dodwell, D., Haywood, L., Earl, H., Stein, R., Herring, K., MacKenzie, M., Makris, A., Gaunt, C., Southgate, E., & Morelli, N. (2026). 253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham. European Journal of Cancer , 237(Supplement 1), 118-119. Article 116516. https://doi.org/10.1016/j.ejca.2026.116516

Rea, D. ; Beggs, A.D. ; Efstathiou, E. et al. / 253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham. In: European Journal of Cancer . 2026 ; Vol. 237, No. Supplement 1. pp. 118-119.

@article{c23898d2c9e84715a42066059139174e,

title = "253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham",

author = "D. Rea and A.D. Beggs and E. Efstathiou and J.D. Stockton and R.M. Worledge and \{Escribano Gonzalez\}, C. and E. Turner and S. Pirrie and H. Cain and D. Cameron and D. Dodwell and L. Haywood and H. Earl and R. Stein and K. Herring and M. MacKenzie and A. Makris and C. Gaunt and E. Southgate and N. Morelli",

year = "2026",

month = mar,

day = "27",

doi = "10.1016/j.ejca.2026.116516",

language = "English",

volume = "237",

pages = "118--119",

journal = "European Journal of Cancer ",

issn = "0959-8049",

publisher = "Elsevier",

number = "Supplement 1",

note = "15th European Breast Cancer Conference, EBCC-15 ; Conference date: 25-03-2026 Through 27-03-2026",

}

Rea, D , Beggs, AD , Efstathiou, E , Stockton, JD, Worledge, RM, Escribano Gonzalez, C , Turner, E , Pirrie, S, Cain, H, Cameron, D, Dodwell, D, Haywood, L, Earl, H, Stein, R, Herring, K, MacKenzie, M, Makris, A, Gaunt, C, Southgate, E & Morelli, N 2026, '253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham', European Journal of Cancer , vol. 237, no. Supplement 1, 116516, pp. 118-119. https://doi.org/10.1016/j.ejca.2026.116516

253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham. / Rea, D.; Beggs, A.D.; Efstathiou, E. et al.
In: European Journal of Cancer , Vol. 237, No. Supplement 1, 116516, 27.03.2026, p. 118-119.

Research output: Contribution to journal › Abstract › peer-review

TY - JOUR

T1 - 253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham

AU - Rea, D.

AU - Beggs, A.D.

AU - Efstathiou, E.

AU - Stockton, J.D.

AU - Worledge, R.M.

AU - Escribano Gonzalez, C.

AU - Turner, E.

AU - Pirrie, S.

AU - Cain, H.

AU - Cameron, D.

AU - Dodwell, D.

AU - Haywood, L.

AU - Earl, H.

AU - Stein, R.

AU - Herring, K.

AU - MacKenzie, M.

AU - Makris, A.

AU - Gaunt, C.

AU - Southgate, E.

AU - Morelli, N.

PY - 2026/3/27

Y1 - 2026/3/27

U2 - 10.1016/j.ejca.2026.116516

DO - 10.1016/j.ejca.2026.116516

M3 - Abstract

SN - 0959-8049

VL - 237

SP - 118

EP - 119

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Supplement 1

M1 - 116516

T2 - 15th European Breast Cancer Conference

Y2 - 25 March 2026 through 27 March 2026

ER -

Rea D , Beggs AD , Efstathiou E , Stockton JD, Worledge RM, Escribano Gonzalez C et al. 253 (PB-061) Poster Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham. European Journal of Cancer . 2026 Mar 27;237(Supplement 1):118-119. 116516. doi: 10.1016/j.ejca.2026.116516